Myopia in children does not just blur vision — it progresses every year, increasing the risk of serious eye disease in later life. Ortho-K overnight lenses and low-dose atropine are clinically proven to slow that progression.
Many parents believe myopia is simply a matter of stronger glasses each year. In fact, progressive myopia increases the risk of retinal detachment, glaucoma, macular degeneration, and cataracts — conditions that can cause permanent vision loss in adulthood.
The best myopia control strategy depends on your child's age, degree of myopia, and lifestyle. We offer all evidence-based options and help you choose the right approach.
We measure corneal topography, axial length, pupil size, and refraction to determine whether Ortho-K is suitable and to design the correct lens parameters.
Each Ortho-K lens is individually designed using your corneal topography map. We trial fit in-clinic and verify the fit before dispensing.
After the first overnight wear, you return the next morning so we can assess the corneal reshaping pattern and adjust the prescription if needed.
We monitor corneal topography changes and visual acuity at 1 week and 1 month to confirm optimal reshaping and comfort.
Axial length measurement every 6 months confirms whether progression is being controlled. We adjust the myopia management strategy based on objective data.
Ortho-K is most effective for children aged 7–18 with myopia between -0.75D and -6.00D and minimal astigmatism. It is particularly well-suited for active children involved in sports who dislike daytime glasses or contact lenses. Adults seeking freedom from daytime correction may also benefit — though myopia control effects are primarily relevant in children whose eyes are still growing.
Treatment · Pan-India
In-clinic in Chennai & Hyderabad — telehealth for Delhi, Mumbai and 5 more cities.
